Bronchiolitis.
After completing this article, readers should be able to: 1. Recognize the clinical presentation of bronchiolitis. 2. Be aware of the recommendations made in the current American Academy of Pediatrics clinical practice guideline for diagnosis and management of bronchiolitis. 3. Describe the role of laboratory testing in the diagnosis of bronchiolitis. 4. Delineate the efficacy of current therapeutic interventions in the treatment of bronchiolitis. 5. Discuss the evaluation for serious bacterial infections in patients who have bronchiolitis. 6. Outline the prognosis and risk of recurrent wheezing in patients diagnosed with bronchiolitis.
Wagner
Tamara
T
Doernbecher Children's Hospital, Oregon Health & Science University, Portland, OR, USA.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000998:Antiviral Agents / Q000627:therapeutic use; D001988:Bronchiolitis / Q000175:diagnosis* / Q000628:therapy*; D001993:Bronchodilator Agents / Q000627:therapeutic use; D002648:Child; D005440:Fluid Therapy; D006801:Humans; D010102:Oxygen Inhalation Therapy; D000069455:Palivizumab; D013396:Suction
D000900:Anti-Bacterial Agents; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000998:Antiviral Agents; D001993:Bronchodilator Agents; D000069455:Palivizumab